Medical Care
Global Animal Blood Plasma and Derivatives Market Research Report 2025
- Mar 11, 25
- ID: 7243
- Pages: 72
- Figures: 80
- Views: 1
The global market for Animal Blood Plasma and Derivatives was valued at US$ 1078 million in the year 2024 and is projected to reach a revised size of US$ 1460 million by 2031, growing at a CAGR of 4.5% during the forecast period.
According to Our PET Supplies Research Center, the global pet industry reached $ 261 billion in 2022, a year-on-year increase of 11.3%. The United States gains the highest pet penetration rate and becomes the largest pet market. According to the American Pet Products Association (APPA), 66% of American households keep pets, and the total industry sales was about US$136.8 billion, an increase of 10.8% over 2021. According to IVH, the German pet products industry association, the number of pets in Germany reached 33.4 million in 2022, with a total turnover of nearly €6.5 billion. The 2023 China Pet Industry Trend Insight White Paper released by JD shows that the market size of the four major pet physical commodities is increasing year by year: pet supplies account for 45%, pet staple food accounts for nearly 35%, pet snacks account for 12%, and pet medicine and health care account for 220%.
This report aims to provide a comprehensive presentation of the global market for Animal Blood Plasma and Derivatives, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Animal Blood Plasma and Derivatives.
The Animal Blood Plasma and Derivatives market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Animal Blood Plasma and Derivatives market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Animal Blood Plasma and Derivatives companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Proliant Inc.
Thermo Fisher Scientific, Inc.
Merck KGaA
Kraeber & Co GmbH
LAMPIRE Biological Laboratories, Inc.
Lake Immunogenics, Inc.
Rocky Mountain Biologicals Inc.
ANZCO Foods Ltd.
Auckland BioSciences Ltd.
Bovogen Biologicals Pty Ltd.
Segment by Type
Immunoglobulin
Fibrinogen
Serum Albumin
Fetal Bovine Serum
Thrombin
New Born Calf Serum
Segment by Application
Food & Beverages
Pharmaceuticals
Cosmetics
Feed
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Animal Blood Plasma and Derivatives company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
According to Our PET Supplies Research Center, the global pet industry reached $ 261 billion in 2022, a year-on-year increase of 11.3%. The United States gains the highest pet penetration rate and becomes the largest pet market. According to the American Pet Products Association (APPA), 66% of American households keep pets, and the total industry sales was about US$136.8 billion, an increase of 10.8% over 2021. According to IVH, the German pet products industry association, the number of pets in Germany reached 33.4 million in 2022, with a total turnover of nearly €6.5 billion. The 2023 China Pet Industry Trend Insight White Paper released by JD shows that the market size of the four major pet physical commodities is increasing year by year: pet supplies account for 45%, pet staple food accounts for nearly 35%, pet snacks account for 12%, and pet medicine and health care account for 220%.
This report aims to provide a comprehensive presentation of the global market for Animal Blood Plasma and Derivatives, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Animal Blood Plasma and Derivatives.
The Animal Blood Plasma and Derivatives market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Animal Blood Plasma and Derivatives market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Animal Blood Plasma and Derivatives companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Proliant Inc.
Thermo Fisher Scientific, Inc.
Merck KGaA
Kraeber & Co GmbH
LAMPIRE Biological Laboratories, Inc.
Lake Immunogenics, Inc.
Rocky Mountain Biologicals Inc.
ANZCO Foods Ltd.
Auckland BioSciences Ltd.
Bovogen Biologicals Pty Ltd.
Segment by Type
Immunoglobulin
Fibrinogen
Serum Albumin
Fetal Bovine Serum
Thrombin
New Born Calf Serum
Segment by Application
Food & Beverages
Pharmaceuticals
Cosmetics
Feed
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Animal Blood Plasma and Derivatives company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Animal Blood Plasma and Derivatives Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Immunoglobulin
1.2.3 Fibrinogen
1.2.4 Serum Albumin
1.2.5 Fetal Bovine Serum
1.2.6 Thrombin
1.2.7 New Born Calf Serum
1.3 Market by Application
1.3.1 Global Animal Blood Plasma and Derivatives Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Food & Beverages
1.3.3 Pharmaceuticals
1.3.4 Cosmetics
1.3.5 Feed
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Animal Blood Plasma and Derivatives Market Perspective (2020-2031)
2.2 Global Animal Blood Plasma and Derivatives Growth Trends by Region
2.2.1 Global Animal Blood Plasma and Derivatives Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Animal Blood Plasma and Derivatives Historic Market Size by Region (2020-2025)
2.2.3 Animal Blood Plasma and Derivatives Forecasted Market Size by Region (2026-2031)
2.3 Animal Blood Plasma and Derivatives Market Dynamics
2.3.1 Animal Blood Plasma and Derivatives Industry Trends
2.3.2 Animal Blood Plasma and Derivatives Market Drivers
2.3.3 Animal Blood Plasma and Derivatives Market Challenges
2.3.4 Animal Blood Plasma and Derivatives Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Animal Blood Plasma and Derivatives Players by Revenue
3.1.1 Global Top Animal Blood Plasma and Derivatives Players by Revenue (2020-2025)
3.1.2 Global Animal Blood Plasma and Derivatives Revenue Market Share by Players (2020-2025)
3.2 Global Animal Blood Plasma and Derivatives Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Animal Blood Plasma and Derivatives Revenue
3.4 Global Animal Blood Plasma and Derivatives Market Concentration Ratio
3.4.1 Global Animal Blood Plasma and Derivatives Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Animal Blood Plasma and Derivatives Revenue in 2024
3.5 Global Key Players of Animal Blood Plasma and Derivatives Head office and Area Served
3.6 Global Key Players of Animal Blood Plasma and Derivatives, Product and Application
3.7 Global Key Players of Animal Blood Plasma and Derivatives, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Animal Blood Plasma and Derivatives Breakdown Data by Type
4.1 Global Animal Blood Plasma and Derivatives Historic Market Size by Type (2020-2025)
4.2 Global Animal Blood Plasma and Derivatives Forecasted Market Size by Type (2026-2031)
5 Animal Blood Plasma and Derivatives Breakdown Data by Application
5.1 Global Animal Blood Plasma and Derivatives Historic Market Size by Application (2020-2025)
5.2 Global Animal Blood Plasma and Derivatives Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Animal Blood Plasma and Derivatives Market Size (2020-2031)
6.2 North America Animal Blood Plasma and Derivatives Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Animal Blood Plasma and Derivatives Market Size by Country (2020-2025)
6.4 North America Animal Blood Plasma and Derivatives Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Animal Blood Plasma and Derivatives Market Size (2020-2031)
7.2 Europe Animal Blood Plasma and Derivatives Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Animal Blood Plasma and Derivatives Market Size by Country (2020-2025)
7.4 Europe Animal Blood Plasma and Derivatives Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Animal Blood Plasma and Derivatives Market Size (2020-2031)
8.2 Asia-Pacific Animal Blood Plasma and Derivatives Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Animal Blood Plasma and Derivatives Market Size by Region (2020-2025)
8.4 Asia-Pacific Animal Blood Plasma and Derivatives Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Animal Blood Plasma and Derivatives Market Size (2020-2031)
9.2 Latin America Animal Blood Plasma and Derivatives Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Animal Blood Plasma and Derivatives Market Size by Country (2020-2025)
9.4 Latin America Animal Blood Plasma and Derivatives Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Animal Blood Plasma and Derivatives Market Size (2020-2031)
10.2 Middle East & Africa Animal Blood Plasma and Derivatives Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Animal Blood Plasma and Derivatives Market Size by Country (2020-2025)
10.4 Middle East & Africa Animal Blood Plasma and Derivatives Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Proliant Inc.
11.1.1 Proliant Inc. Company Details
11.1.2 Proliant Inc. Business Overview
11.1.3 Proliant Inc. Animal Blood Plasma and Derivatives Introduction
11.1.4 Proliant Inc. Revenue in Animal Blood Plasma and Derivatives Business (2020-2025)
11.1.5 Proliant Inc. Recent Development
11.2 Thermo Fisher Scientific, Inc.
11.2.1 Thermo Fisher Scientific, Inc. Company Details
11.2.2 Thermo Fisher Scientific, Inc. Business Overview
11.2.3 Thermo Fisher Scientific, Inc. Animal Blood Plasma and Derivatives Introduction
11.2.4 Thermo Fisher Scientific, Inc. Revenue in Animal Blood Plasma and Derivatives Business (2020-2025)
11.2.5 Thermo Fisher Scientific, Inc. Recent Development
11.3 Merck KGaA
11.3.1 Merck KGaA Company Details
11.3.2 Merck KGaA Business Overview
11.3.3 Merck KGaA Animal Blood Plasma and Derivatives Introduction
11.3.4 Merck KGaA Revenue in Animal Blood Plasma and Derivatives Business (2020-2025)
11.3.5 Merck KGaA Recent Development
11.4 Kraeber & Co GmbH
11.4.1 Kraeber & Co GmbH Company Details
11.4.2 Kraeber & Co GmbH Business Overview
11.4.3 Kraeber & Co GmbH Animal Blood Plasma and Derivatives Introduction
11.4.4 Kraeber & Co GmbH Revenue in Animal Blood Plasma and Derivatives Business (2020-2025)
11.4.5 Kraeber & Co GmbH Recent Development
11.5 LAMPIRE Biological Laboratories, Inc.
11.5.1 LAMPIRE Biological Laboratories, Inc. Company Details
11.5.2 LAMPIRE Biological Laboratories, Inc. Business Overview
11.5.3 LAMPIRE Biological Laboratories, Inc. Animal Blood Plasma and Derivatives Introduction
11.5.4 LAMPIRE Biological Laboratories, Inc. Revenue in Animal Blood Plasma and Derivatives Business (2020-2025)
11.5.5 LAMPIRE Biological Laboratories, Inc. Recent Development
11.6 Lake Immunogenics, Inc.
11.6.1 Lake Immunogenics, Inc. Company Details
11.6.2 Lake Immunogenics, Inc. Business Overview
11.6.3 Lake Immunogenics, Inc. Animal Blood Plasma and Derivatives Introduction
11.6.4 Lake Immunogenics, Inc. Revenue in Animal Blood Plasma and Derivatives Business (2020-2025)
11.6.5 Lake Immunogenics, Inc. Recent Development
11.7 Rocky Mountain Biologicals Inc.
11.7.1 Rocky Mountain Biologicals Inc. Company Details
11.7.2 Rocky Mountain Biologicals Inc. Business Overview
11.7.3 Rocky Mountain Biologicals Inc. Animal Blood Plasma and Derivatives Introduction
11.7.4 Rocky Mountain Biologicals Inc. Revenue in Animal Blood Plasma and Derivatives Business (2020-2025)
11.7.5 Rocky Mountain Biologicals Inc. Recent Development
11.8 ANZCO Foods Ltd.
11.8.1 ANZCO Foods Ltd. Company Details
11.8.2 ANZCO Foods Ltd. Business Overview
11.8.3 ANZCO Foods Ltd. Animal Blood Plasma and Derivatives Introduction
11.8.4 ANZCO Foods Ltd. Revenue in Animal Blood Plasma and Derivatives Business (2020-2025)
11.8.5 ANZCO Foods Ltd. Recent Development
11.9 Auckland BioSciences Ltd.
11.9.1 Auckland BioSciences Ltd. Company Details
11.9.2 Auckland BioSciences Ltd. Business Overview
11.9.3 Auckland BioSciences Ltd. Animal Blood Plasma and Derivatives Introduction
11.9.4 Auckland BioSciences Ltd. Revenue in Animal Blood Plasma and Derivatives Business (2020-2025)
11.9.5 Auckland BioSciences Ltd. Recent Development
11.10 Bovogen Biologicals Pty Ltd.
11.10.1 Bovogen Biologicals Pty Ltd. Company Details
11.10.2 Bovogen Biologicals Pty Ltd. Business Overview
11.10.3 Bovogen Biologicals Pty Ltd. Animal Blood Plasma and Derivatives Introduction
11.10.4 Bovogen Biologicals Pty Ltd. Revenue in Animal Blood Plasma and Derivatives Business (2020-2025)
11.10.5 Bovogen Biologicals Pty Ltd. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Animal Blood Plasma and Derivatives Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Immunoglobulin
1.2.3 Fibrinogen
1.2.4 Serum Albumin
1.2.5 Fetal Bovine Serum
1.2.6 Thrombin
1.2.7 New Born Calf Serum
1.3 Market by Application
1.3.1 Global Animal Blood Plasma and Derivatives Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Food & Beverages
1.3.3 Pharmaceuticals
1.3.4 Cosmetics
1.3.5 Feed
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Animal Blood Plasma and Derivatives Market Perspective (2020-2031)
2.2 Global Animal Blood Plasma and Derivatives Growth Trends by Region
2.2.1 Global Animal Blood Plasma and Derivatives Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Animal Blood Plasma and Derivatives Historic Market Size by Region (2020-2025)
2.2.3 Animal Blood Plasma and Derivatives Forecasted Market Size by Region (2026-2031)
2.3 Animal Blood Plasma and Derivatives Market Dynamics
2.3.1 Animal Blood Plasma and Derivatives Industry Trends
2.3.2 Animal Blood Plasma and Derivatives Market Drivers
2.3.3 Animal Blood Plasma and Derivatives Market Challenges
2.3.4 Animal Blood Plasma and Derivatives Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Animal Blood Plasma and Derivatives Players by Revenue
3.1.1 Global Top Animal Blood Plasma and Derivatives Players by Revenue (2020-2025)
3.1.2 Global Animal Blood Plasma and Derivatives Revenue Market Share by Players (2020-2025)
3.2 Global Animal Blood Plasma and Derivatives Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Animal Blood Plasma and Derivatives Revenue
3.4 Global Animal Blood Plasma and Derivatives Market Concentration Ratio
3.4.1 Global Animal Blood Plasma and Derivatives Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Animal Blood Plasma and Derivatives Revenue in 2024
3.5 Global Key Players of Animal Blood Plasma and Derivatives Head office and Area Served
3.6 Global Key Players of Animal Blood Plasma and Derivatives, Product and Application
3.7 Global Key Players of Animal Blood Plasma and Derivatives, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Animal Blood Plasma and Derivatives Breakdown Data by Type
4.1 Global Animal Blood Plasma and Derivatives Historic Market Size by Type (2020-2025)
4.2 Global Animal Blood Plasma and Derivatives Forecasted Market Size by Type (2026-2031)
5 Animal Blood Plasma and Derivatives Breakdown Data by Application
5.1 Global Animal Blood Plasma and Derivatives Historic Market Size by Application (2020-2025)
5.2 Global Animal Blood Plasma and Derivatives Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Animal Blood Plasma and Derivatives Market Size (2020-2031)
6.2 North America Animal Blood Plasma and Derivatives Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Animal Blood Plasma and Derivatives Market Size by Country (2020-2025)
6.4 North America Animal Blood Plasma and Derivatives Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Animal Blood Plasma and Derivatives Market Size (2020-2031)
7.2 Europe Animal Blood Plasma and Derivatives Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Animal Blood Plasma and Derivatives Market Size by Country (2020-2025)
7.4 Europe Animal Blood Plasma and Derivatives Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Animal Blood Plasma and Derivatives Market Size (2020-2031)
8.2 Asia-Pacific Animal Blood Plasma and Derivatives Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Animal Blood Plasma and Derivatives Market Size by Region (2020-2025)
8.4 Asia-Pacific Animal Blood Plasma and Derivatives Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Animal Blood Plasma and Derivatives Market Size (2020-2031)
9.2 Latin America Animal Blood Plasma and Derivatives Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Animal Blood Plasma and Derivatives Market Size by Country (2020-2025)
9.4 Latin America Animal Blood Plasma and Derivatives Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Animal Blood Plasma and Derivatives Market Size (2020-2031)
10.2 Middle East & Africa Animal Blood Plasma and Derivatives Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Animal Blood Plasma and Derivatives Market Size by Country (2020-2025)
10.4 Middle East & Africa Animal Blood Plasma and Derivatives Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Proliant Inc.
11.1.1 Proliant Inc. Company Details
11.1.2 Proliant Inc. Business Overview
11.1.3 Proliant Inc. Animal Blood Plasma and Derivatives Introduction
11.1.4 Proliant Inc. Revenue in Animal Blood Plasma and Derivatives Business (2020-2025)
11.1.5 Proliant Inc. Recent Development
11.2 Thermo Fisher Scientific, Inc.
11.2.1 Thermo Fisher Scientific, Inc. Company Details
11.2.2 Thermo Fisher Scientific, Inc. Business Overview
11.2.3 Thermo Fisher Scientific, Inc. Animal Blood Plasma and Derivatives Introduction
11.2.4 Thermo Fisher Scientific, Inc. Revenue in Animal Blood Plasma and Derivatives Business (2020-2025)
11.2.5 Thermo Fisher Scientific, Inc. Recent Development
11.3 Merck KGaA
11.3.1 Merck KGaA Company Details
11.3.2 Merck KGaA Business Overview
11.3.3 Merck KGaA Animal Blood Plasma and Derivatives Introduction
11.3.4 Merck KGaA Revenue in Animal Blood Plasma and Derivatives Business (2020-2025)
11.3.5 Merck KGaA Recent Development
11.4 Kraeber & Co GmbH
11.4.1 Kraeber & Co GmbH Company Details
11.4.2 Kraeber & Co GmbH Business Overview
11.4.3 Kraeber & Co GmbH Animal Blood Plasma and Derivatives Introduction
11.4.4 Kraeber & Co GmbH Revenue in Animal Blood Plasma and Derivatives Business (2020-2025)
11.4.5 Kraeber & Co GmbH Recent Development
11.5 LAMPIRE Biological Laboratories, Inc.
11.5.1 LAMPIRE Biological Laboratories, Inc. Company Details
11.5.2 LAMPIRE Biological Laboratories, Inc. Business Overview
11.5.3 LAMPIRE Biological Laboratories, Inc. Animal Blood Plasma and Derivatives Introduction
11.5.4 LAMPIRE Biological Laboratories, Inc. Revenue in Animal Blood Plasma and Derivatives Business (2020-2025)
11.5.5 LAMPIRE Biological Laboratories, Inc. Recent Development
11.6 Lake Immunogenics, Inc.
11.6.1 Lake Immunogenics, Inc. Company Details
11.6.2 Lake Immunogenics, Inc. Business Overview
11.6.3 Lake Immunogenics, Inc. Animal Blood Plasma and Derivatives Introduction
11.6.4 Lake Immunogenics, Inc. Revenue in Animal Blood Plasma and Derivatives Business (2020-2025)
11.6.5 Lake Immunogenics, Inc. Recent Development
11.7 Rocky Mountain Biologicals Inc.
11.7.1 Rocky Mountain Biologicals Inc. Company Details
11.7.2 Rocky Mountain Biologicals Inc. Business Overview
11.7.3 Rocky Mountain Biologicals Inc. Animal Blood Plasma and Derivatives Introduction
11.7.4 Rocky Mountain Biologicals Inc. Revenue in Animal Blood Plasma and Derivatives Business (2020-2025)
11.7.5 Rocky Mountain Biologicals Inc. Recent Development
11.8 ANZCO Foods Ltd.
11.8.1 ANZCO Foods Ltd. Company Details
11.8.2 ANZCO Foods Ltd. Business Overview
11.8.3 ANZCO Foods Ltd. Animal Blood Plasma and Derivatives Introduction
11.8.4 ANZCO Foods Ltd. Revenue in Animal Blood Plasma and Derivatives Business (2020-2025)
11.8.5 ANZCO Foods Ltd. Recent Development
11.9 Auckland BioSciences Ltd.
11.9.1 Auckland BioSciences Ltd. Company Details
11.9.2 Auckland BioSciences Ltd. Business Overview
11.9.3 Auckland BioSciences Ltd. Animal Blood Plasma and Derivatives Introduction
11.9.4 Auckland BioSciences Ltd. Revenue in Animal Blood Plasma and Derivatives Business (2020-2025)
11.9.5 Auckland BioSciences Ltd. Recent Development
11.10 Bovogen Biologicals Pty Ltd.
11.10.1 Bovogen Biologicals Pty Ltd. Company Details
11.10.2 Bovogen Biologicals Pty Ltd. Business Overview
11.10.3 Bovogen Biologicals Pty Ltd. Animal Blood Plasma and Derivatives Introduction
11.10.4 Bovogen Biologicals Pty Ltd. Revenue in Animal Blood Plasma and Derivatives Business (2020-2025)
11.10.5 Bovogen Biologicals Pty Ltd. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Animal Blood Plasma and Derivatives Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Immunoglobulin
Table 3. Key Players of Fibrinogen
Table 4. Key Players of Serum Albumin
Table 5. Key Players of Fetal Bovine Serum
Table 6. Key Players of Thrombin
Table 7. Key Players of New Born Calf Serum
Table 8. Global Animal Blood Plasma and Derivatives Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 9. Global Animal Blood Plasma and Derivatives Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 10. Global Animal Blood Plasma and Derivatives Market Size by Region (2020-2025) & (US$ Million)
Table 11. Global Animal Blood Plasma and Derivatives Market Share by Region (2020-2025)
Table 12. Global Animal Blood Plasma and Derivatives Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 13. Global Animal Blood Plasma and Derivatives Market Share by Region (2026-2031)
Table 14. Animal Blood Plasma and Derivatives Market Trends
Table 15. Animal Blood Plasma and Derivatives Market Drivers
Table 16. Animal Blood Plasma and Derivatives Market Challenges
Table 17. Animal Blood Plasma and Derivatives Market Restraints
Table 18. Global Animal Blood Plasma and Derivatives Revenue by Players (2020-2025) & (US$ Million)
Table 19. Global Animal Blood Plasma and Derivatives Market Share by Players (2020-2025)
Table 20. Global Top Animal Blood Plasma and Derivatives Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Animal Blood Plasma and Derivatives as of 2024)
Table 21. Ranking of Global Top Animal Blood Plasma and Derivatives Companies by Revenue (US$ Million) in 2024
Table 22. Global 5 Largest Players Market Share by Animal Blood Plasma and Derivatives Revenue (CR5 and HHI) & (2020-2025)
Table 23. Global Key Players of Animal Blood Plasma and Derivatives, Headquarters and Area Served
Table 24. Global Key Players of Animal Blood Plasma and Derivatives, Product and Application
Table 25. Global Key Players of Animal Blood Plasma and Derivatives, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Animal Blood Plasma and Derivatives Market Size by Type (2020-2025) & (US$ Million)
Table 28. Global Animal Blood Plasma and Derivatives Revenue Market Share by Type (2020-2025)
Table 29. Global Animal Blood Plasma and Derivatives Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 30. Global Animal Blood Plasma and Derivatives Revenue Market Share by Type (2026-2031)
Table 31. Global Animal Blood Plasma and Derivatives Market Size by Application (2020-2025) & (US$ Million)
Table 32. Global Animal Blood Plasma and Derivatives Revenue Market Share by Application (2020-2025)
Table 33. Global Animal Blood Plasma and Derivatives Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 34. Global Animal Blood Plasma and Derivatives Revenue Market Share by Application (2026-2031)
Table 35. North America Animal Blood Plasma and Derivatives Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. North America Animal Blood Plasma and Derivatives Market Size by Country (2020-2025) & (US$ Million)
Table 37. North America Animal Blood Plasma and Derivatives Market Size by Country (2026-2031) & (US$ Million)
Table 38. Europe Animal Blood Plasma and Derivatives Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 39. Europe Animal Blood Plasma and Derivatives Market Size by Country (2020-2025) & (US$ Million)
Table 40. Europe Animal Blood Plasma and Derivatives Market Size by Country (2026-2031) & (US$ Million)
Table 41. Asia-Pacific Animal Blood Plasma and Derivatives Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 42. Asia-Pacific Animal Blood Plasma and Derivatives Market Size by Region (2020-2025) & (US$ Million)
Table 43. Asia-Pacific Animal Blood Plasma and Derivatives Market Size by Region (2026-2031) & (US$ Million)
Table 44. Latin America Animal Blood Plasma and Derivatives Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Latin America Animal Blood Plasma and Derivatives Market Size by Country (2020-2025) & (US$ Million)
Table 46. Latin America Animal Blood Plasma and Derivatives Market Size by Country (2026-2031) & (US$ Million)
Table 47. Middle East & Africa Animal Blood Plasma and Derivatives Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 48. Middle East & Africa Animal Blood Plasma and Derivatives Market Size by Country (2020-2025) & (US$ Million)
Table 49. Middle East & Africa Animal Blood Plasma and Derivatives Market Size by Country (2026-2031) & (US$ Million)
Table 50. Proliant Inc. Company Details
Table 51. Proliant Inc. Business Overview
Table 52. Proliant Inc. Animal Blood Plasma and Derivatives Product
Table 53. Proliant Inc. Revenue in Animal Blood Plasma and Derivatives Business (2020-2025) & (US$ Million)
Table 54. Proliant Inc. Recent Development
Table 55. Thermo Fisher Scientific, Inc. Company Details
Table 56. Thermo Fisher Scientific, Inc. Business Overview
Table 57. Thermo Fisher Scientific, Inc. Animal Blood Plasma and Derivatives Product
Table 58. Thermo Fisher Scientific, Inc. Revenue in Animal Blood Plasma and Derivatives Business (2020-2025) & (US$ Million)
Table 59. Thermo Fisher Scientific, Inc. Recent Development
Table 60. Merck KGaA Company Details
Table 61. Merck KGaA Business Overview
Table 62. Merck KGaA Animal Blood Plasma and Derivatives Product
Table 63. Merck KGaA Revenue in Animal Blood Plasma and Derivatives Business (2020-2025) & (US$ Million)
Table 64. Merck KGaA Recent Development
Table 65. Kraeber & Co GmbH Company Details
Table 66. Kraeber & Co GmbH Business Overview
Table 67. Kraeber & Co GmbH Animal Blood Plasma and Derivatives Product
Table 68. Kraeber & Co GmbH Revenue in Animal Blood Plasma and Derivatives Business (2020-2025) & (US$ Million)
Table 69. Kraeber & Co GmbH Recent Development
Table 70. LAMPIRE Biological Laboratories, Inc. Company Details
Table 71. LAMPIRE Biological Laboratories, Inc. Business Overview
Table 72. LAMPIRE Biological Laboratories, Inc. Animal Blood Plasma and Derivatives Product
Table 73. LAMPIRE Biological Laboratories, Inc. Revenue in Animal Blood Plasma and Derivatives Business (2020-2025) & (US$ Million)
Table 74. LAMPIRE Biological Laboratories, Inc. Recent Development
Table 75. Lake Immunogenics, Inc. Company Details
Table 76. Lake Immunogenics, Inc. Business Overview
Table 77. Lake Immunogenics, Inc. Animal Blood Plasma and Derivatives Product
Table 78. Lake Immunogenics, Inc. Revenue in Animal Blood Plasma and Derivatives Business (2020-2025) & (US$ Million)
Table 79. Lake Immunogenics, Inc. Recent Development
Table 80. Rocky Mountain Biologicals Inc. Company Details
Table 81. Rocky Mountain Biologicals Inc. Business Overview
Table 82. Rocky Mountain Biologicals Inc. Animal Blood Plasma and Derivatives Product
Table 83. Rocky Mountain Biologicals Inc. Revenue in Animal Blood Plasma and Derivatives Business (2020-2025) & (US$ Million)
Table 84. Rocky Mountain Biologicals Inc. Recent Development
Table 85. ANZCO Foods Ltd. Company Details
Table 86. ANZCO Foods Ltd. Business Overview
Table 87. ANZCO Foods Ltd. Animal Blood Plasma and Derivatives Product
Table 88. ANZCO Foods Ltd. Revenue in Animal Blood Plasma and Derivatives Business (2020-2025) & (US$ Million)
Table 89. ANZCO Foods Ltd. Recent Development
Table 90. Auckland BioSciences Ltd. Company Details
Table 91. Auckland BioSciences Ltd. Business Overview
Table 92. Auckland BioSciences Ltd. Animal Blood Plasma and Derivatives Product
Table 93. Auckland BioSciences Ltd. Revenue in Animal Blood Plasma and Derivatives Business (2020-2025) & (US$ Million)
Table 94. Auckland BioSciences Ltd. Recent Development
Table 95. Bovogen Biologicals Pty Ltd. Company Details
Table 96. Bovogen Biologicals Pty Ltd. Business Overview
Table 97. Bovogen Biologicals Pty Ltd. Animal Blood Plasma and Derivatives Product
Table 98. Bovogen Biologicals Pty Ltd. Revenue in Animal Blood Plasma and Derivatives Business (2020-2025) & (US$ Million)
Table 99. Bovogen Biologicals Pty Ltd. Recent Development
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
Table 103. Authors List of This Report
List of Figures
Figure 1. Animal Blood Plasma and Derivatives Picture
Figure 2. Global Animal Blood Plasma and Derivatives Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Animal Blood Plasma and Derivatives Market Share by Type: 2024 VS 2031
Figure 4. Immunoglobulin Features
Figure 5. Fibrinogen Features
Figure 6. Serum Albumin Features
Figure 7. Fetal Bovine Serum Features
Figure 8. Thrombin Features
Figure 9. New Born Calf Serum Features
Figure 10. Global Animal Blood Plasma and Derivatives Market Size by Application (2020-2031) & (US$ Million)
Figure 11. Global Animal Blood Plasma and Derivatives Market Share by Application: 2024 VS 2031
Figure 12. Food & Beverages Case Studies
Figure 13. Pharmaceuticals Case Studies
Figure 14. Cosmetics Case Studies
Figure 15. Feed Case Studies
Figure 16. Others Case Studies
Figure 17. Animal Blood Plasma and Derivatives Report Years Considered
Figure 18. Global Animal Blood Plasma and Derivatives Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 19. Global Animal Blood Plasma and Derivatives Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 20. Global Animal Blood Plasma and Derivatives Market Share by Region: 2024 VS 2031
Figure 21. Global Animal Blood Plasma and Derivatives Market Share by Players in 2024
Figure 22. Global Top Animal Blood Plasma and Derivatives Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Animal Blood Plasma and Derivatives as of 2024)
Figure 23. The Top 10 and 5 Players Market Share by Animal Blood Plasma and Derivatives Revenue in 2024
Figure 24. North America Animal Blood Plasma and Derivatives Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. North America Animal Blood Plasma and Derivatives Market Share by Country (2020-2031)
Figure 26. United States Animal Blood Plasma and Derivatives Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Canada Animal Blood Plasma and Derivatives Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Europe Animal Blood Plasma and Derivatives Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Europe Animal Blood Plasma and Derivatives Market Share by Country (2020-2031)
Figure 30. Germany Animal Blood Plasma and Derivatives Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. France Animal Blood Plasma and Derivatives Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. U.K. Animal Blood Plasma and Derivatives Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Italy Animal Blood Plasma and Derivatives Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Russia Animal Blood Plasma and Derivatives Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Nordic Countries Animal Blood Plasma and Derivatives Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Asia-Pacific Animal Blood Plasma and Derivatives Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Asia-Pacific Animal Blood Plasma and Derivatives Market Share by Region (2020-2031)
Figure 38. China Animal Blood Plasma and Derivatives Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Japan Animal Blood Plasma and Derivatives Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. South Korea Animal Blood Plasma and Derivatives Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Southeast Asia Animal Blood Plasma and Derivatives Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. India Animal Blood Plasma and Derivatives Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Australia Animal Blood Plasma and Derivatives Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Latin America Animal Blood Plasma and Derivatives Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Latin America Animal Blood Plasma and Derivatives Market Share by Country (2020-2031)
Figure 46. Mexico Animal Blood Plasma and Derivatives Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Brazil Animal Blood Plasma and Derivatives Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Middle East & Africa Animal Blood Plasma and Derivatives Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Middle East & Africa Animal Blood Plasma and Derivatives Market Share by Country (2020-2031)
Figure 50. Turkey Animal Blood Plasma and Derivatives Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. Saudi Arabia Animal Blood Plasma and Derivatives Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 52. UAE Animal Blood Plasma and Derivatives Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 53. Proliant Inc. Revenue Growth Rate in Animal Blood Plasma and Derivatives Business (2020-2025)
Figure 54. Thermo Fisher Scientific, Inc. Revenue Growth Rate in Animal Blood Plasma and Derivatives Business (2020-2025)
Figure 55. Merck KGaA Revenue Growth Rate in Animal Blood Plasma and Derivatives Business (2020-2025)
Figure 56. Kraeber & Co GmbH Revenue Growth Rate in Animal Blood Plasma and Derivatives Business (2020-2025)
Figure 57. LAMPIRE Biological Laboratories, Inc. Revenue Growth Rate in Animal Blood Plasma and Derivatives Business (2020-2025)
Figure 58. Lake Immunogenics, Inc. Revenue Growth Rate in Animal Blood Plasma and Derivatives Business (2020-2025)
Figure 59. Rocky Mountain Biologicals Inc. Revenue Growth Rate in Animal Blood Plasma and Derivatives Business (2020-2025)
Figure 60. ANZCO Foods Ltd. Revenue Growth Rate in Animal Blood Plasma and Derivatives Business (2020-2025)
Figure 61. Auckland BioSciences Ltd. Revenue Growth Rate in Animal Blood Plasma and Derivatives Business (2020-2025)
Figure 62. Bovogen Biologicals Pty Ltd. Revenue Growth Rate in Animal Blood Plasma and Derivatives Business (2020-2025)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Table 1. Global Animal Blood Plasma and Derivatives Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Immunoglobulin
Table 3. Key Players of Fibrinogen
Table 4. Key Players of Serum Albumin
Table 5. Key Players of Fetal Bovine Serum
Table 6. Key Players of Thrombin
Table 7. Key Players of New Born Calf Serum
Table 8. Global Animal Blood Plasma and Derivatives Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 9. Global Animal Blood Plasma and Derivatives Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 10. Global Animal Blood Plasma and Derivatives Market Size by Region (2020-2025) & (US$ Million)
Table 11. Global Animal Blood Plasma and Derivatives Market Share by Region (2020-2025)
Table 12. Global Animal Blood Plasma and Derivatives Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 13. Global Animal Blood Plasma and Derivatives Market Share by Region (2026-2031)
Table 14. Animal Blood Plasma and Derivatives Market Trends
Table 15. Animal Blood Plasma and Derivatives Market Drivers
Table 16. Animal Blood Plasma and Derivatives Market Challenges
Table 17. Animal Blood Plasma and Derivatives Market Restraints
Table 18. Global Animal Blood Plasma and Derivatives Revenue by Players (2020-2025) & (US$ Million)
Table 19. Global Animal Blood Plasma and Derivatives Market Share by Players (2020-2025)
Table 20. Global Top Animal Blood Plasma and Derivatives Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Animal Blood Plasma and Derivatives as of 2024)
Table 21. Ranking of Global Top Animal Blood Plasma and Derivatives Companies by Revenue (US$ Million) in 2024
Table 22. Global 5 Largest Players Market Share by Animal Blood Plasma and Derivatives Revenue (CR5 and HHI) & (2020-2025)
Table 23. Global Key Players of Animal Blood Plasma and Derivatives, Headquarters and Area Served
Table 24. Global Key Players of Animal Blood Plasma and Derivatives, Product and Application
Table 25. Global Key Players of Animal Blood Plasma and Derivatives, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Animal Blood Plasma and Derivatives Market Size by Type (2020-2025) & (US$ Million)
Table 28. Global Animal Blood Plasma and Derivatives Revenue Market Share by Type (2020-2025)
Table 29. Global Animal Blood Plasma and Derivatives Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 30. Global Animal Blood Plasma and Derivatives Revenue Market Share by Type (2026-2031)
Table 31. Global Animal Blood Plasma and Derivatives Market Size by Application (2020-2025) & (US$ Million)
Table 32. Global Animal Blood Plasma and Derivatives Revenue Market Share by Application (2020-2025)
Table 33. Global Animal Blood Plasma and Derivatives Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 34. Global Animal Blood Plasma and Derivatives Revenue Market Share by Application (2026-2031)
Table 35. North America Animal Blood Plasma and Derivatives Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. North America Animal Blood Plasma and Derivatives Market Size by Country (2020-2025) & (US$ Million)
Table 37. North America Animal Blood Plasma and Derivatives Market Size by Country (2026-2031) & (US$ Million)
Table 38. Europe Animal Blood Plasma and Derivatives Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 39. Europe Animal Blood Plasma and Derivatives Market Size by Country (2020-2025) & (US$ Million)
Table 40. Europe Animal Blood Plasma and Derivatives Market Size by Country (2026-2031) & (US$ Million)
Table 41. Asia-Pacific Animal Blood Plasma and Derivatives Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 42. Asia-Pacific Animal Blood Plasma and Derivatives Market Size by Region (2020-2025) & (US$ Million)
Table 43. Asia-Pacific Animal Blood Plasma and Derivatives Market Size by Region (2026-2031) & (US$ Million)
Table 44. Latin America Animal Blood Plasma and Derivatives Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Latin America Animal Blood Plasma and Derivatives Market Size by Country (2020-2025) & (US$ Million)
Table 46. Latin America Animal Blood Plasma and Derivatives Market Size by Country (2026-2031) & (US$ Million)
Table 47. Middle East & Africa Animal Blood Plasma and Derivatives Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 48. Middle East & Africa Animal Blood Plasma and Derivatives Market Size by Country (2020-2025) & (US$ Million)
Table 49. Middle East & Africa Animal Blood Plasma and Derivatives Market Size by Country (2026-2031) & (US$ Million)
Table 50. Proliant Inc. Company Details
Table 51. Proliant Inc. Business Overview
Table 52. Proliant Inc. Animal Blood Plasma and Derivatives Product
Table 53. Proliant Inc. Revenue in Animal Blood Plasma and Derivatives Business (2020-2025) & (US$ Million)
Table 54. Proliant Inc. Recent Development
Table 55. Thermo Fisher Scientific, Inc. Company Details
Table 56. Thermo Fisher Scientific, Inc. Business Overview
Table 57. Thermo Fisher Scientific, Inc. Animal Blood Plasma and Derivatives Product
Table 58. Thermo Fisher Scientific, Inc. Revenue in Animal Blood Plasma and Derivatives Business (2020-2025) & (US$ Million)
Table 59. Thermo Fisher Scientific, Inc. Recent Development
Table 60. Merck KGaA Company Details
Table 61. Merck KGaA Business Overview
Table 62. Merck KGaA Animal Blood Plasma and Derivatives Product
Table 63. Merck KGaA Revenue in Animal Blood Plasma and Derivatives Business (2020-2025) & (US$ Million)
Table 64. Merck KGaA Recent Development
Table 65. Kraeber & Co GmbH Company Details
Table 66. Kraeber & Co GmbH Business Overview
Table 67. Kraeber & Co GmbH Animal Blood Plasma and Derivatives Product
Table 68. Kraeber & Co GmbH Revenue in Animal Blood Plasma and Derivatives Business (2020-2025) & (US$ Million)
Table 69. Kraeber & Co GmbH Recent Development
Table 70. LAMPIRE Biological Laboratories, Inc. Company Details
Table 71. LAMPIRE Biological Laboratories, Inc. Business Overview
Table 72. LAMPIRE Biological Laboratories, Inc. Animal Blood Plasma and Derivatives Product
Table 73. LAMPIRE Biological Laboratories, Inc. Revenue in Animal Blood Plasma and Derivatives Business (2020-2025) & (US$ Million)
Table 74. LAMPIRE Biological Laboratories, Inc. Recent Development
Table 75. Lake Immunogenics, Inc. Company Details
Table 76. Lake Immunogenics, Inc. Business Overview
Table 77. Lake Immunogenics, Inc. Animal Blood Plasma and Derivatives Product
Table 78. Lake Immunogenics, Inc. Revenue in Animal Blood Plasma and Derivatives Business (2020-2025) & (US$ Million)
Table 79. Lake Immunogenics, Inc. Recent Development
Table 80. Rocky Mountain Biologicals Inc. Company Details
Table 81. Rocky Mountain Biologicals Inc. Business Overview
Table 82. Rocky Mountain Biologicals Inc. Animal Blood Plasma and Derivatives Product
Table 83. Rocky Mountain Biologicals Inc. Revenue in Animal Blood Plasma and Derivatives Business (2020-2025) & (US$ Million)
Table 84. Rocky Mountain Biologicals Inc. Recent Development
Table 85. ANZCO Foods Ltd. Company Details
Table 86. ANZCO Foods Ltd. Business Overview
Table 87. ANZCO Foods Ltd. Animal Blood Plasma and Derivatives Product
Table 88. ANZCO Foods Ltd. Revenue in Animal Blood Plasma and Derivatives Business (2020-2025) & (US$ Million)
Table 89. ANZCO Foods Ltd. Recent Development
Table 90. Auckland BioSciences Ltd. Company Details
Table 91. Auckland BioSciences Ltd. Business Overview
Table 92. Auckland BioSciences Ltd. Animal Blood Plasma and Derivatives Product
Table 93. Auckland BioSciences Ltd. Revenue in Animal Blood Plasma and Derivatives Business (2020-2025) & (US$ Million)
Table 94. Auckland BioSciences Ltd. Recent Development
Table 95. Bovogen Biologicals Pty Ltd. Company Details
Table 96. Bovogen Biologicals Pty Ltd. Business Overview
Table 97. Bovogen Biologicals Pty Ltd. Animal Blood Plasma and Derivatives Product
Table 98. Bovogen Biologicals Pty Ltd. Revenue in Animal Blood Plasma and Derivatives Business (2020-2025) & (US$ Million)
Table 99. Bovogen Biologicals Pty Ltd. Recent Development
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
Table 103. Authors List of This Report
List of Figures
Figure 1. Animal Blood Plasma and Derivatives Picture
Figure 2. Global Animal Blood Plasma and Derivatives Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Animal Blood Plasma and Derivatives Market Share by Type: 2024 VS 2031
Figure 4. Immunoglobulin Features
Figure 5. Fibrinogen Features
Figure 6. Serum Albumin Features
Figure 7. Fetal Bovine Serum Features
Figure 8. Thrombin Features
Figure 9. New Born Calf Serum Features
Figure 10. Global Animal Blood Plasma and Derivatives Market Size by Application (2020-2031) & (US$ Million)
Figure 11. Global Animal Blood Plasma and Derivatives Market Share by Application: 2024 VS 2031
Figure 12. Food & Beverages Case Studies
Figure 13. Pharmaceuticals Case Studies
Figure 14. Cosmetics Case Studies
Figure 15. Feed Case Studies
Figure 16. Others Case Studies
Figure 17. Animal Blood Plasma and Derivatives Report Years Considered
Figure 18. Global Animal Blood Plasma and Derivatives Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 19. Global Animal Blood Plasma and Derivatives Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 20. Global Animal Blood Plasma and Derivatives Market Share by Region: 2024 VS 2031
Figure 21. Global Animal Blood Plasma and Derivatives Market Share by Players in 2024
Figure 22. Global Top Animal Blood Plasma and Derivatives Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Animal Blood Plasma and Derivatives as of 2024)
Figure 23. The Top 10 and 5 Players Market Share by Animal Blood Plasma and Derivatives Revenue in 2024
Figure 24. North America Animal Blood Plasma and Derivatives Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. North America Animal Blood Plasma and Derivatives Market Share by Country (2020-2031)
Figure 26. United States Animal Blood Plasma and Derivatives Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Canada Animal Blood Plasma and Derivatives Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Europe Animal Blood Plasma and Derivatives Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Europe Animal Blood Plasma and Derivatives Market Share by Country (2020-2031)
Figure 30. Germany Animal Blood Plasma and Derivatives Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. France Animal Blood Plasma and Derivatives Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. U.K. Animal Blood Plasma and Derivatives Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Italy Animal Blood Plasma and Derivatives Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Russia Animal Blood Plasma and Derivatives Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Nordic Countries Animal Blood Plasma and Derivatives Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Asia-Pacific Animal Blood Plasma and Derivatives Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Asia-Pacific Animal Blood Plasma and Derivatives Market Share by Region (2020-2031)
Figure 38. China Animal Blood Plasma and Derivatives Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Japan Animal Blood Plasma and Derivatives Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. South Korea Animal Blood Plasma and Derivatives Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Southeast Asia Animal Blood Plasma and Derivatives Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. India Animal Blood Plasma and Derivatives Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Australia Animal Blood Plasma and Derivatives Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Latin America Animal Blood Plasma and Derivatives Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Latin America Animal Blood Plasma and Derivatives Market Share by Country (2020-2031)
Figure 46. Mexico Animal Blood Plasma and Derivatives Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Brazil Animal Blood Plasma and Derivatives Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Middle East & Africa Animal Blood Plasma and Derivatives Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Middle East & Africa Animal Blood Plasma and Derivatives Market Share by Country (2020-2031)
Figure 50. Turkey Animal Blood Plasma and Derivatives Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. Saudi Arabia Animal Blood Plasma and Derivatives Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 52. UAE Animal Blood Plasma and Derivatives Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 53. Proliant Inc. Revenue Growth Rate in Animal Blood Plasma and Derivatives Business (2020-2025)
Figure 54. Thermo Fisher Scientific, Inc. Revenue Growth Rate in Animal Blood Plasma and Derivatives Business (2020-2025)
Figure 55. Merck KGaA Revenue Growth Rate in Animal Blood Plasma and Derivatives Business (2020-2025)
Figure 56. Kraeber & Co GmbH Revenue Growth Rate in Animal Blood Plasma and Derivatives Business (2020-2025)
Figure 57. LAMPIRE Biological Laboratories, Inc. Revenue Growth Rate in Animal Blood Plasma and Derivatives Business (2020-2025)
Figure 58. Lake Immunogenics, Inc. Revenue Growth Rate in Animal Blood Plasma and Derivatives Business (2020-2025)
Figure 59. Rocky Mountain Biologicals Inc. Revenue Growth Rate in Animal Blood Plasma and Derivatives Business (2020-2025)
Figure 60. ANZCO Foods Ltd. Revenue Growth Rate in Animal Blood Plasma and Derivatives Business (2020-2025)
Figure 61. Auckland BioSciences Ltd. Revenue Growth Rate in Animal Blood Plasma and Derivatives Business (2020-2025)
Figure 62. Bovogen Biologicals Pty Ltd. Revenue Growth Rate in Animal Blood Plasma and Derivatives Business (2020-2025)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Multi-Channel Temperature Controllers Market Research Report 2025
Mar 14, 25
Global Waterproof Action Cameras Market Research Report 2025
Mar 14, 25
Global Infrared IP Cameras Market Research Report 2025
Mar 14, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232